BlackRock Updates ARGENX SE Stake as of Dec 31, 2023
Ticker: ARGX · Form: SC 13G/A · Filed: Feb 1, 2024 · CIK: 1697862
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investing
TL;DR
**BlackRock just updated its ARGENX SE stake, signaling continued institutional interest.**
AI Summary
BlackRock Inc. filed an amended SC 13G/A on February 1, 2024, indicating its ownership in ARGENX SE's Common Stock as of December 31, 2023. This filing, an amendment number 2, updates their previous disclosures under Rule 13d-1(b). This matters to investors because BlackRock is a major institutional investor, and changes in their holdings can signal their confidence in ARGENX SE's future prospects, potentially influencing other investors' decisions.
Why It Matters
This filing shows BlackRock's continued significant, though passive, interest in ARGENX SE, a biotechnology company, which can be a vote of confidence for current and potential shareholders.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of institutional ownership and does not indicate any immediate negative risks for the company or its stock.
Analyst Insight
An investor should note BlackRock's continued passive stake in ARGENX SE, but this filing alone doesn't provide enough information to make a buy/sell decision. It's a routine disclosure, not an active investment signal.
Key Players & Entities
- BlackRock Inc. (company) — the institutional investor filing the SC 13G/A
- ARGENX SE (company) — the subject company whose securities are being reported
- December 31, 2023 (date) — the date of the event requiring the filing
- February 1, 2024 (date) — the date the SC 13G/A was filed
FAQ
What type of filing is this document?
This document is an SC 13G/A, which is an amendment to a Schedule 13G filing, specifically Amendment No: 2, as stated in the filing.
Who is the filer of this SC 13G/A?
The filer of this SC 13G/A is BlackRock Inc., as indicated in the 'FILED BY' section of the filing.
What is the subject company of this filing?
The subject company is ARGENX SE, as stated under 'Name of Issuer' and in the 'SUBJECT COMPANY' data section.
What is the date of the event that required this filing?
The date of the event which required the filing of this statement is December 31, 2023, as explicitly mentioned in the filing.
Under which rule was this Schedule 13G/A filed?
This Schedule 13G/A was filed under Rule 13d-1(b), as indicated by the '[X] Rule 13d-1(b)' checkbox selection in the document.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on February 1, 2024 regarding ARGENX SE (ARGX).